Magnesium prevents anemia and reduces inflammation in diabetics

Researchers at the University of Ibadan in Nigeria have found that taking magnesium supplements may prevent amnesia and reduce inflammation in people with diabetes. The study, which was published in the Journal of Dietary Supplements, looked at the effect of oral magnesium administration on some markers of anemia and inflammation in diabetic mice.

• Magnesium has been known to improve glucose utilization in diabetes, but data on its effects on anemia and inflammatory markers in diabetes is limited.
• For the study, the researchers caused diabetes in mice by giving them a single dose of alloxan.
• Then, they gave the mice 0.2 milliliters (ml) of distilled water, 100 milligrams per kilogram (mg/kg) body weight of magnesium, 250 mg/kg body weight of magnesium, or 1 international unit (IU) per kg of insulin.
• All treatments were given every day for 14 days.
• After the final treatment, the researchers collected blood samples from each mice to measure anemic and inflammatory markers.
• The results revealed that the treatment of alloxan-induced diabetic mice with magnesium improved their anemic state.
• Magnesium treatment also reduced hematologic and metabolic inflammatory markers.

Based on the findings of the study, the researchers concluded that treatment with magnesium may prevent anemia and fight inflammation in diabetics.

To read more studies that discuss natural ways on improving the health of diabetics, visit DiabetesScienceNews.com.

Journal Reference:

Ige AO, Adewoye EO. ORAL MAGNESIUM TREATMENT REDUCES ANEMIA AND LEVELS OF INFLAMMATORY MARKERS IN EXPERIMENTAL DIABETES. Journal of Dietary Supplements. 26 July 2016; 14(1): 76-88. DOI: 10.1080/19390211.2016.1205700